managing semaglutide side effects Ozempic — Everything You Need to Know Semaglutide Side Effects Week by

Abdominal pain

CHALLENGE-MIG is the first and only clinical trial comparing two anti-calcitonin gene-related peptide (CGRP) medicines, Emgality and Nurtec ODT, which work differently

Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic liver disease closely associated with the epidemics of obesity and type 2 diabetes mellitus (T2DM), but without licensed pharmacological treatment to date

Secondary endpoints include change in neural response to visual food cues and to sweet-tasting substances as assessed by functional MRI, change in body weight, change in fat mass and change in eating behaviour and food intake

Both are now widely prescribed for weight management under brand names most people recognize: Ozempic and Wegovy for semaglutide, Mounjaro and Zepbound for tirzepatide.

As competition intensifies in obesity, companies are increasingly looking for the next wave of high-value opportunities in adjacent metabolic and gastrointestinal diseases